YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

St. Louis biotech startup raises $105M in funding round

Posted online

St. Louis biotech startup Arch Oncology raised $105 million in a funding round.

The round was led by Eventide Asset Management, Cowen Healthcare Investments and 3x5 Partners.

Arch Oncology is developing biologic therapies to treat patients with tumors and hematologic malignancies.

Read more from the St. Louis Business Journal.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
From the Ground Up: Republic Intermediate School

The Republic School District is on track to open its Intermediate School for fifth- and sixth-grade students for the 2025-26 academic year.

Most Read
Update cookies preferences